Figure 1.
Study population attrition.
aBased on the presence of ICD versions 9 and 10 codes for ovarian, fallopian tube, and/or peritoneal cancer (ICD-9: 183x, 158x; ICD-10: C56x, C57.0x, C48x) with two or more documented clinical visits.
bPatients with borderline histology were excluded.
cPatients with niraparib 2LM who did not have a non-canceled medication order for niraparib were excluded.
1L, first-line; 2L, second-line; 2LM, second-line maintenance; AS, active surveillance; ECOG, Eastern Cooperative Oncology Group; ICD, International Classification of Disease; OC, ovarian cancer; PARP, poly(ADP-ribose) polymerase; wt, wild type.